Programme topics include:
- The European Biotechnology Success Story Toolkit – Hear directly from the funders and the funded
- The Translation of Fundamental Science into a Commercial Drug Discovery Company
- One Year On – an update on the Office for Life Sciences
- Money, Money, Money In the City – A panel discussion of the benefits of a Stock Market listing
- Sizing up the Capital Markets and Utilising Alternative Financing Strategies to Grow your Life Science Business – New rules, strategies and tactics to win in this tough market
- An investor‘s wishlist – What are Fund Managers and VCs Looking for in 2010 and Beyond
- How Pfizer is Staying Innovative and Competitive in the New Decade
- Nothing Ventured, Nothing Gained –The Increasing Importance of Corporate Venture Funds in the Life Sciences Sector
Who should attend:
- CEO's, VP's, CFO's, CSO's
- Business Development Executives
- Licensing Executives
- Technology Transfer Managers
- Research and Development Scientists / Professionals
Attendees will gain:
- Access to the finance sector
- Access to alternative funding options
- Access to key individuals within the biotech sector
- Access to big pharma
- Access to early stage, innovative companies
- Access to partnering and network opportunities
To view the programme click here
